North America Fibromyalgia Market to 2032

Overview

The North America Fibromyalgia Market is expected to reach a 1,120.54 USD Million by 2032 and is projected to grow at a CAGR of 6.72% from 2025 to 2032.

Revenue, 2024 (USD Million)
746.97
Forecast, 2032 (USD Million)
1,120.54
CAGR, 2024 - 2032
6.72%
Report Coverage
North America

North America Fibromyalgia Market 2018-2032 USD Million

North America Fibromyalgia Market, Key Findings (2025-2032)

Market Growth and Projections:

  • Market Size (2024): 746.97 USD Million
  • Projected Market Size (2032): 1,120.54 USD Million
  • CAGR (2025-2032): 6.72%

Key Findings of North America Fibromyalgia Market

  • The North America Fibromyalgia Market was valued at 746.97 USD Million in 2024.
  • The North America Fibromyalgia Market is likely to grow at a CAGR of 6.72% during the forecast period of 2024 to 2032.
  • In 2024, the Largest segment Direct Tender in Distribution Channel Segment accounted for the largest share of the market with a revenue of 500.06 USD Million
  • The fastest growing segment Primary (Idiopathic) Fibromyalgia in Type Segment grew Fastest with a CAGR of 7.42% during the forecast period from 2024 to 2032.

North America Fibromyalgia Market Scope

North America Fibromyalgia Market Segmentation & Scope
Type
  • Primary (Idiopathic) Fibromyalgia
  • Brain & Hormonal Abnormalities (Secondary)
End User
  • Hospital
  • Pain Clinics
  • Others
Distribution Channel
  • Direct Tender
  • Retail Sales
  • Others

North America Fibromyalgia Market Data Coverage Insights

Study Period 2024-2032
Base Year 2022
Unit Revenue in USD Million
Market Value in 2024 746.97 USD Million
Market Value in 2032 1,120.54 USD Million
CAGR (2025-2032) 6.72%
Historic Data 2016-2023
Market Segments Covered Type,End User,Distribution Channel

Regional Insights:

  • Leading Market (2024-2032): North America, leading in terms of revenue 746.97 USD Million in 2024
    • Key Country: U.S., leading in terms of revenue with value of 746.97 USD Million in 2024.

Segments and Scope

  • North America Fibromyalgia Market to 2032, By Type
    • Primary (Idiopathic) Fibromyalgia is the largest segment in North America Fibromyalgia Market to 2032 with a revenue of 400.23 USD Million in the year 2024.
    • Primary (Idiopathic) Fibromyalgia is the Fastest growing segment in North America Fibromyalgia Market to 2032 with a Growth rate of 7.42 % in forecast period 2025-2032.
  • North America Fibromyalgia Market to 2032, By End User
    • Hospital is the largest segment in North America Fibromyalgia Market to 2032 with a revenue of 459.41 USD Million in the year 2024.
    • Hospital is the Fastest growing segment in North America Fibromyalgia Market to 2032 with a Growth rate of 7.04 % in forecast period 2025-2032.
  • North America Fibromyalgia Market to 2032, By Distribution Channel
    • Direct Tender is the largest segment in North America Fibromyalgia Market to 2032 with a revenue of 500.06 USD Million in the year 2024.
    • Direct Tender is the Fastest growing segment in North America Fibromyalgia Market to 2032 with a Growth rate of 7.01 % in forecast period 2025-2032.

North America Fibromyalgia Market Company Share Analysis

 
North America Fibromyalgia Market Company Share Analysis
North America Fibromyalgia Market Company Share Analysis

North America Fibromyalgia Market Geographical Sales Distribution, 2018-2032 USD Million

North America Fibromyalgia Market Geographical Sales Distribution, 2018-2032 USD Million

North America Fibromyalgia Market Company Profiling

North America Fibromyalgia Market Company Profiling
Frequently Asked Questions
The North America Fibromyalgia Market is segmented based on Segmentation Type,End User,Distribution Channel.
North America Fibromyalgia Market was valued at USD 746.97(Revenue in USD Million) in 2022.
North America Fibromyalgia Market is projected to grow at a CAGR of 6.72% during the forecast period of 2024 to 2032.
The Direct Tender segment is expected to dominate the North America Fibromyalgia Market, holding a largest market share of 500.06 USD Million in 2024

North America Fibromyalgia Market Scope

North America Fibromyalgia Market Segmentation & Scope
Type
  • Primary (Idiopathic) Fibromyalgia
  • Brain & Hormonal Abnormalities (Secondary)
End User
  • Hospital
  • Pain Clinics
  • Others
Distribution Channel
  • Direct Tender
  • Retail Sales
  • Others
Frequently Asked Questions
The North America Fibromyalgia Market is segmented based on Segmentation Type,End User,Distribution Channel.
North America Fibromyalgia Market was valued at USD 746.97(Revenue in USD Million) in 2022.
North America Fibromyalgia Market is projected to grow at a CAGR of 6.72% during the forecast period of 2024 to 2032.
The estimated market value of the North America Fibromyalgia Market for final year is USD 1,120.54 (USD Million).

North America Fibromyalgia Market Company Profiling

North America Fibromyalgia Market Company Profiling
Frequently Asked Questions
The North America Fibromyalgia Market is segmented based on Segmentation Type,End User,Distribution Channel.
North America Fibromyalgia Market was valued at USD 746.97(Revenue in USD Million) in 2022.
North America Fibromyalgia Market is projected to grow at a CAGR of 6.72% during the forecast period of 2024 to 2032.
The estimated market value of the North America Fibromyalgia Market for final year is USD 1,120.54 (USD Million).

Related Markets

HAVE A QUESTION?

Get expert advice on the right strategy for your business at no cost. We also offer customized subscription plans and affordable discounts for startups and universities.